Eversept Partners, LP Pacira Bio Sciences, Inc. Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Nov 08, 2023	BUY	$30.8 - $52.47 $4.09 Million - $6.96 Million	132,655 New	132,655 $6.96 Million
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $4.09 Million - $6.96 Million	132,655 New	132,655 $6.96 Million
Q1 2018 May 14, 2018	SELL	$29.98 - $46.35 $752,498 - $1.16 Million	-25,100 Closed	0 $0
Q4 2017 Nov 08, 2023	BUY	$31.85 - $46.95 $799,435 - $1.18 Million	25,100 New	25,100 $1.15 Billion
Q4 2017 Feb 12, 2018	BUY	$31.85 - $46.95 $799,435 - $1.18 Million	25,100	25,100 $1.15 Million

260

49.8M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.06B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.